Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

Zekai Tahir Burak Women's Health Research and Education Hospital

Status and phase: Unknown; Phase 4

Conditions: Transient Tachypnea of Newborn

Treatments: Device: Nasal SIMV; Device: nasal CPAP

Study type: Interventional

Funder types: Other

Identifiers

NCT01499238

4

Details and patient eligibility

About

The investigators aimed to compare the efficacy of nasal SIMV and nasal CPAP in patients with wet lung.

Full description

We aimed to compare two types of ventilatory support in cases of transient tachypnea of newborn who are >35 gestational week.

Enrollment: 40 estimated patients

Sex: All

Ages: 2 hours to 3 days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• >35 gestational week
• wetlung

Exclusion criteria

• major congenital anomalies

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

nasal SIMV

Active Comparator group

Description:

rate: 30-50/min, PIP: 16, PEEP: 4-6, fİO2: 40%

Treatment:

Device: Nasal SIMV

nasal CPAP

Active Comparator group

Description:

PEEP: 4-6 mmHg, Fio2: 40%

Treatment:

Device: nasal CPAP